4 completed. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
Follow Dysentery: new trials by email Literature Review of Dysentery trials Research Report on Dysentery
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Rifaximin in Preventing Campylobacteriosis Rifaximin intervention, Placebo intervention - Dysentery, Diarrhea | Phase 2 / Phase 3 | Completed | Johns Hopkins Bloomberg School of Public Health | 30 | 2014-10-01 | 2018-11-20 |
| Rifaximin for Prevention of Travellers' Diarrhea Rifaximin, Placebo - Diarrhea | Phase 3 | Completed | Bausch Health Americas, Inc. | 210 | 2005-06-01 | 2019-12-18 |
| Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel Shigella conjugate vaccines - Shigellosis | Phase 3 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2799 | 2003-01-01 | 2012-06-22 |
| Zinc Supplementation in Shigella Patients Children in the zinc group received 20 mg of elemental zinc as acetate per day in a twice-daily dose for two weeks. - Testing Effect of Intervention | Phase 3 | Completed | International Centre for Diarrhoeal Disease Research, Bangladesh | 56 | 1999-01-01 | 2006-05-03 |
Dysentery, Bacillary (3) · Diarrhea (2) · Campylobacter Infections (1) · Escherichia coli Infections (1)
Bacterial Infections (4) · Bacterial Infections and Mycoses (4) · Digestive System Diseases (4) · Gastroenteritis (4) · Gastrointestinal Diseases (4) · Gram-Negative Bacterial Infections (4) · Infections (4) · Intestinal Diseases (4) · Enterobacteriaceae Infections (3) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Signs and Symptoms, Digestive (2)
Rifaximin (1)
Bausch Health Americas, Inc. (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · International Centre for Diarrhoeal Disease Research, Bangladesh (1) · Johns Hopkins Bloomberg School of Public Health (1)
Israel (1) · Mexico (1) · United States (1)
Kawsar Talaat, M.D. (1) · Rachel Schneerson, MD (1) · Swapan Kumar Roy, MBBS, M.Sc, Ph. D (1)
PMID 20412178, PMID 11692292, PMID 12809830, PMID 15017618, PMID 17382603, PMID 17554249, PMID 18809665, PMID 19842970, PMID 20056180, PMID 20086085, PMID 21050319, PMID 21896097, PMID 22864805, PMID 23840001, PMID 29145631